# Pharmacelera funding: rounds and investors

> Pharmacelera has raised $7.1M across 1 round since 2026. Investors include Inveready and Clave Capital. Every round with its source.

Source: https://millionrounds.com/company/pharmacelera (Millionrounds; every figure on the page links to its filing or article)

Spain · [Venture startup](https://millionrounds.com/companies)

# Who invested in *Pharmacelera*

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 9 months ago

Funding summary Updated 26 Oct 2026

**$7.1M** raised across 1 round since 2026, from 1 source

- **Latest round:** Venture, $7.1M Feb 2026
- **Investors:** 2

See who backed them

## The rounds

- **Feb 2026** Venture **$7.1M** [Inveready](https://millionrounds.com/fund/inveready) [Clave Capital](https://millionrounds.com/fund/clave-capital) Source recorded

## Founders and team

From Pharmacelera's own website: 3 founders, 20 on the team.

**Enric Gibert** CEO & Co-founder

**Enric Herrero** CTO & Co-founder

**Javier Luque** CSO & Co-founder

- **Greta Cánovas** CFO
- **Remy Hoffmann** CFO
- **Cindy Tingle** Head of US Operations and Business Development
- **Albert Herrero** Senior Engineer
- **Albert Turon** Research Intern
- **Alex Kèller** Intern Software Engineer
- **Ana Caballero** Business Developer Manager
- **Brian Medel** Research intern
- **Carlos Cruz** Research Intern
- **Daniel Alvarez** Principal Scientist
- **Fernando Martin** Business Developer Manager
- **Ignacio Prieto** Board Member
- **Javier Vázquez** Senior Researcher
- **Jingqi Fu** Research Intern
- **Joan Bigorra** Board of Directors
- **Manel Lopez** Principal Scientist
- **Matthew Medcalf** Senior Applications Scientist
- **Miguel Rivero** Senior Frontend Developer

And 2 more on the team.

Advisers *Alessandro Monge*

## Everyone who backed them

[Inveready](https://millionrounds.com/fund/inveready) VC firm **1** round

[Clave Capital](https://millionrounds.com/fund/clave-capital) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=pharmacelera).

## Also claim to have backed them

These 2 firms list Pharmacelera as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

[HERAN Partners](https://millionrounds.com/fund/heran-partners) VC firm Per its own site

[Namarel](https://millionrounds.com/fund/namarel) Growth equity Per its own site

## Quick answers about Pharmacelera

### Who invested in Pharmacelera?

Pharmacelera's investors include Inveready and Clave Capital.

### How much has Pharmacelera raised?

Pharmacelera has raised $7.1M across 1 round since 2026.

### When did Pharmacelera last raise?

Pharmacelera's most recent round was a Venture of $7.1M in Feb 2026.

### What was Pharmacelera's biggest round?

Its most recent round, $7.1M in Feb 2026, is also its largest on record.

### Who backed Pharmacelera first?

Pharmacelera's first round on record, in Feb 2026, was backed by Inveready and Clave Capital.

### What stage is Pharmacelera at?

Pharmacelera's latest named round is a Venture, in Feb 2026.

### Where is Pharmacelera based?

Pharmacelera is based in Spain.

## Companies like Pharmacelera

In the same sector, and raised in the last eighteen months.

[**HAWK Biosystems** $3.9M · Oct 2026](https://millionrounds.com/company/hawk-biosystems)[**Anaconda Biomed** $73M · Sept 2026](https://millionrounds.com/company/anaconda-biomed)[**Vaxdyn** $26M · Sept 2026](https://millionrounds.com/company/vaxdyn)[**iPremom** $17M · Sept 2026](https://millionrounds.com/company/ipremom)[**Connecta Therapeutics** $6.1M · Sept 2026](https://millionrounds.com/company/connecta-therapeutics)[**Flomics** $1.1M · Sept 2026](https://millionrounds.com/company/flomics)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app